Page last updated: 2024-08-22

clodronic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

clodronic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, T; Jiang, Y; Le, K; Xi, Z; Xiao, Y; Xu, M; Yang, W; Zhang, Q; Zhou, J	1

Other Studies

1 other study(ies) available for clodronic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model. International immunopharmacology, 2019, Volume: 76 Topics: Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Clodronic Acid; Female; Liposomes; Macrophages; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Triple Negative Breast Neoplasms	2019

Article

Year

Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.

International immunopharmacology, 2019, Volume: 76

Topics: Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Clodronic Acid; Female; Liposomes; Macrophages; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Triple Negative Breast Neoplasms

2019